CareMetx

CareMetx is a specialty hub services and technology company focused on improving the lives of individuals facing complex health challenges. It partners with biopharmaceutical and device manufacturers to offer reimbursement support and clinical services for patients prescribed innovative products. CareMetx employs a compassionate and experienced workforce dedicated to high-quality patient care. The company leverages its proprietary digital hub platform to streamline specialty reimbursement processes, featuring guided workflows and customizable triggers that facilitate quick implementation. This platform provides real-time access to critical decision-making data, enhancing efficiency and reducing costs while ensuring patients can access necessary treatments promptly. Additionally, CareMetx offers mobile solutions, dashboards, and portals to effectively track and manage the patient journey from intake to outcomes.

Brent Barber

COO

3 past transactions

PhyzData

Acquisition in 2021
PhyzData is a digital health company focused on patient engagement, brand access, data/analytics, and actionable insights in the biotech drug market. Through our focus, PhyzData utilizes its first to market Prescription Triage Network™ to manage and streamline the biotech prescription process among Physician, Patient, Specialty Pharmacy, Drug Manufacturer, and Health Insurance Plan. Our PTN™ solution enables Patient and Physician brand access, ensures the prescription is triaged to a mandated Specialty Pharmacy, and captures real-time unique data and analytics to drive informed business decisions.

BioSolutia

Acquisition in 2018
BioSolutia, Inc. provides launch support, managed care payor and reimbursement strategy, and customized pharmaceutical services. The company was founded in 2004 and is based in Lake Mary, Florida. As of October 3, 2018, BioSolutia, Inc. operates as a subsidiary of CareMetx, LLC.

VirMedica

Acquisition in 2018
Mark Barnes founded VirMedica in 2013 with a mission to break down the commercial barriers that oftentimes impede patient access to specialty products. To accomplish this goal, he knew that today’s service HUB would have to be transformed using the industry’s best technology to automate and simplify provider and patient workflows. VirMedica’s first acquisition was BioMed Intelligence (BMI) – an integrated single application technology platform to power traditional patient access functions for specialty products. VirMedica subsequently completed a significant capital raise that led to the acquisition of TransEngen (TE) – the nation’s premier provider of automated, real-time benefits verification service and to a capital investment into D2 Pharma Consulting (D2) – a leading consulting company with expertise in managed care, commercialization/distribution and business development capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.